Scott is joined by Motley Fool analyst Andrew Legget to talk about medical technology company Nanosonics (ASX:NAN): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy!
See omnystudio.com/listener for privacy information.
